Brief Report: Updated Data From IMscin001 Part 2, a Randomized Phase III Study of Subcutaneous Versus Intravenous Atezolizumab in Patients With Locally Advanced or Metastatic NSCLC

Mauricio Burotto, Zanete Zvirbule, Renzo Alvarez, B. Chewaskulyong, Luis A. Herráez-Baranda, Esther Shearer-Kang, Xiaoyan Liu, Nadia Tosti, Patrick Williams, Amparo Yovanna Castro Sanchez, James A. Zanghi, Enriqueta Felip